Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of Target Ranges to Treat Patients With Parkinson's Disease by Objective Measurement Using the Personal KinetiGraph® (PKG®) Compared to Standard of Care Assessment (TARGET-PD)- A Randomized Controlled Trial

NCT03984305 is registered in ClinicalTrials.gov with Global Kinetics Corporation as lead sponsor.

NCT NCT03984305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of Target Ranges to Treat Patients With Parkinson's Disease by Objective Measurement Using the Personal KinetiGraph® (PKG®) Compared to Standard of Care Assessment (TARGET-PD)- A Randomized Controlled Trial
Lead sponsor
Global Kinetics Corporation
Phase
Not applicable
Overall status
Terminated
Start date
October 15, 2019
Completion date
October 16, 2020
Enrollment
41 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease